SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[AMENDMENT TO LOANOUT AGREEMENT THIS AMENDMENT TO LOANOUT AGREEMENT (“Amendment”) is made and entered into as of May 26, 2009, by and between Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), and Worldwide Officers, Inc. a California Corporation (the “Lender”). Capitalized terms used herein and undefined shall have the meanings set forth in that certain Loanout Agreement (defined in the] [SKYSTAR BIO-PHARMACEUTICAL COMPANY Room 10601, Jiezuo Plaza No. 4, Fenghui Road South Gaoxin District, Xian Province People’s Republic of China May 26, 2009 Mr. Mark D. Chen Suite 10-64 #9 Jianguomenwai Avenue Beijing, P.R. China 100600 Re: Director Offer Letter Dear Mr. Chen: Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), is pleased to offer you a director position on]

By | 2016-03-01T08:05:46+00:00 May 27th, 2009|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: AMENDMENT TO LOANOUT AGREEMENT THIS AMENDMENT TO LOANOUT

[AMENDMENT TO LOANOUT AGREEMENT THIS AMENDMENT TO LOANOUT AGREEMENT (“Amendment”) is made and entered into as of May 26, 2009, by and between Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), and Worldwide Officers, Inc. a California Corporation (the “Lender”). Capitalized terms used herein and undefined shall have the meanings set forth in that certain Loanout Agreement (defined in the] [SKYSTAR BIO-PHARMACEUTICAL COMPANY Room 10601, Jiezuo Plaza No. 4, Fenghui Road South Gaoxin District, Xian Province People’s Republic of China May 26, 2009 Mr. Mark D. Chen Suite 10-64 #9 Jianguomenwai Avenue Beijing, P.R. China 100600 Re: Director Offer Letter Dear Mr. Chen: Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), is pleased to offer you a director position on]

By | 2016-03-01T08:07:36+00:00 May 27th, 2009|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Read More

LONG [eLong,] 6-K: (Original Filing)

[eLong, Inc. Reports First Quarter 2009 Unaudited Financial Results BEIJING, China — May 27, 2009 — eLong, Inc. (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited financial results for the first quarter ended March 31, 2009. Highlights • Total gross revenues net revenues • Travel revenues before business tax and surcharges (figures in RMB 000’s;]

By | 2016-03-02T13:04:40+00:00 May 27th, 2009|Categories: Chinese Stocks, LONG, SEC Original|Tags: , , , , , |0 Comments
Read More

LONG [eLong,] 6-K: eLong, Inc. Reports First Quarter 2009 Unaudited Financial

[eLong, Inc. Reports First Quarter 2009 Unaudited Financial Results BEIJING, China — May 27, 2009 — eLong, Inc. (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited financial results for the first quarter ended March 31, 2009. Highlights • Total gross revenues net revenues • Travel revenues before business tax and surcharges (figures in RMB 000’s;]

By | 2016-03-02T13:06:57+00:00 May 27th, 2009|Categories: Chinese Stocks, LONG, Webplus ver|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 Investments in Infrastructure Expected To Positively Effect Performance This Year New York, New York – May 27, 2009 – Biostar Pharmaceuticals, Inc. (“Biostar” or the “Company”) (OTCBB: BSPM) today reported financial results for the three months ended March 31, 2009. The Company reported revenue of $7,447,664]

By | 2016-03-03T16:19:38+00:00 May 27th, 2009|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings

[Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 Investments in Infrastructure Expected To Positively Effect Performance This Year New York, New York – May 27, 2009 – Biostar Pharmaceuticals, Inc. (“Biostar” or the “Company”) (OTCBB: BSPM) today reported financial results for the three months ended March 31, 2009. The Company reported revenue of $7,447,664]

By | 2016-03-03T16:21:19+00:00 May 27th, 2009|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

CSUN [China Sunergy] 6-K: (Original Filing)

[CHINA SUNERGY ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2009 Nanjing, China – May 27, 2009 – China Sunergy Co., Ltd. (Nasdaq: CSUN), (“China Sunergy” or the “Company”) a specialized solar cell manufacturer based in Nanjing, China, announced today its financial results for the first quarter of 2009. First Quarter Financial Results · Revenues were US$37.0 million, a 14.4%]

By | 2016-03-07T15:24:18+00:00 May 27th, 2009|Categories: Chinese Stocks, CSUN, SEC Original|Tags: , , , , , |0 Comments
Read More

SEED [Origin Agritech] 6-K: (Original Filing)

[Origin Agritech Limited Reports Second Quarter Financial Results Advances from Customers for Q2 09 were RMB 165.21 million from RMB 105.17 million in Q2 08, an increase of 57.09% Deferred Revenues for Q2 09 were RMB 443.40 million from RMB 400.15 million in Q2 08, an increase of 10.80% Origin Agritech Limited (“Origin” or the “Company”) BEIJING--(BUSINESS WIRE)--May 26, 2009--]

By | 2016-03-10T22:13:39+00:00 May 27th, 2009|Categories: Chinese Stocks, SEC Original, SEED|Tags: , , , , , |0 Comments
Read More
Skip to toolbar